Two months after the European Commission published its Competitiveness Compass, we take a deeper look into its strategic vision to enhance the EU’s economic resilience and global competitiveness (following up on our first overview), namely the competition law aspects. The Commission is rather clear that it seeks to establish Europe’s competitiveness as the new “North Star”. However, what is not so clear: Through which paths will the Commission lead us on our journey to this North Star?

The increased political focus on climate and environmental protection has a particular impact on trade with chemicals. In an amendment to the REACH Regulation at the end of 2024, the European Commission banned the use of certain chemicals due to the risk of contamination. In this part of our ESG Briefing series, we provide an overview of the key provisions of the REACH Regulation and its latest amendments.

The European defence industry is undergoing profound strategic transformation. Just last week, the Commission has published its White Paper for European Defence Readiness 2030, attesting “changes of a magnitude not seen since 1945” and boldly stating: “History will not forgive us for inaction.” This shift has also been felt in competition law. Recent policy discussions suggest that the traditional approach to competition enforcement — focusing primarily on market dynamics and consumer welfare — may evolve to incorporate additional considerations, in particular defence interests.

After the Oscar-worthy performance in its opening act, the DMA series is back with a brand-new season, packed with twists, turns, and regulatory cliffhangers. On March 19, 2025, the European Commission stepped into the spotlight with two decisive moves: First, it handed Apple a script rewrite, demanding new specified measures to meet interoperability obligations under the DMA. Second, it preliminarily found Alphabet in breach of the DMA by self-preferencing in Google Search and enforcing restrictive steering rules in Google Play.

In view of the increasingly acute threat situation, driven in particular by growing doubts about the US' loyalty to NATO and the resulting restriction of the conventional and nuclear deterrence, the question arises: How well prepared is Germany for a further escalation of conflicts, especially that with Russia? Should asymmetric warfare - including against Germany - have even more far-reaching consequences, what legal instruments are available to the state in order to remain capable of acting in an external or internal emergency (innerer oder äußerer Notstand)? This briefing sheds light on the security and precautionary laws (Sicherstellungs- und Vorsorgegesetze), which have been rather neglected to date, and which (should) provide the necessary instruments for such situations.

In times of escalating trade wars (see our latest briefing on the EU’s response to the U.S.’ steel and aluminum tariffs), businesses face significant challenges due to increased tariffs, supply chain disruptions, and geopolitical uncertainties. To navigate these complexities, we have put together 8 strategies business can apply while highlighting potential risks.

Already the first Trump administration has restricted international trade by imposing tariffs of up to 25% on imports of steel and aluminium from the European Union (EU), provoking countermeasures by the EU. In 2021, these measures ceased to apply after the EU and United States (US) reached a corresponding agreement. On 12 March 2025, the US revived the tariffs. Again, the action has prompted the EU to implement countermeasures.

On 27 November 2024, Regulation (EU) 2024/3015 (Forced Labour Regulation) was published, aimed at eradicating products made with forced labour from the EU market. The Forced Labour Regulation represents a significant step in the EU's commitment to upholding human rights and promoting ethical supply chains.

BLOMSTEIN, together with lindenpartners, supported DiliTrust, a leading CLM provider in Europe, on its acquisition of the legal tech startup PACTA. The BLOMSTEIN team, led by Roland Stein and Anna Huttenlauch, advised on investment control and merger control aspects of this transaction.

With trade war between China and the US on the doorsteps, implications for EU companies will be manyfold. One possible consequence could be heavily subsidised Chinese products flooding the EU market. Particularly for medical devices, there is an increased probability that this might happen. However, such a development would not meat European companies defenceless.